Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hospital biobank aims to Fast-Track rapid tests for future outbreaks

NCT ID NCT07411729

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large collection of leftover blood, urine, and other samples from 800 hospitalized patients. The samples will be stored with medical data to help researchers develop and evaluate rapid diagnostic tests for emerging infectious diseases and biological threats. No extra procedures are needed—only samples already taken during routine care are used. The goal is to be better prepared for future outbreaks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this biobank could speed up the creation of rapid diagnostic tests for new infectious diseases and bioterrorism threats, improving outbreak response.
What could go wrong
This is an observational registry, not a treatment trial. It collects existing samples and data, so it does not directly test any intervention or guarantee that useful diagnostics will result.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients hospitalized in one of the participating study centers

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥ 18 years old) hospitalized in one of the participating centers at Bicêtre or Paul Brousse hospitals, for whom residual biological samples are available as part of routine care in one or more participating hospital departments. * Covered by, or entitled to, the French social security system (excluding State Medical Aid - AME). * Patient or legal representative/trusted person informed about the registry and having provided written consent to participate. Exclusion Criteria: * Patients under judicial protection (guardianship or curatorship). * Patients deprived of liberty by judicial or administrative decision. * Patients not speaking French and not accompanied by a translator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biological warfare agents are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Communicable Diseases, Emerging infectious disease Zoonoses

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biological warfare agents Communicable diseases Disease outbreaks Emerging infectious diseases Zoonoses

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France

  • CHU Paul Brousse

    RECRUITING

    Villejuif, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.